Seagen Inc Stock Fundamentals
| SGENDelisted Stock | USD 228.74 0.19 0.08% |
Seagen Inc fundamentals help investors to digest information that contributes to Seagen's financial success or failures. It also enables traders to predict the movement of Seagen Stock. The fundamental analysis module provides a way to measure Seagen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Seagen stock.
Seagen |
Seagen Inc Company Return On Equity Analysis
Seagen's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Seagen Return On Equity | -0.28 |
Most of Seagen's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Seagen Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Seagen Inc has a Return On Equity of -0.2793. This is 98.83% lower than that of the Biotechnology sector and 99.23% lower than that of the Health Care industry. The return on equity for all United States stocks is 9.9% lower than that of the firm.
Seagen Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Seagen's current stock value. Our valuation model uses many indicators to compare Seagen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Seagen competition to find correlations between indicators driving Seagen's intrinsic value. More Info.Seagen Inc is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Seagen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Seagen's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Seagen's earnings, one of the primary drivers of an investment's value.Seagen Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Seagen's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Seagen could also be used in its relative valuation, which is a method of valuing Seagen by comparing valuation metrics of similar companies.Seagen is currently under evaluation in return on equity category among related companies.
Seagen Fundamentals
| Return On Equity | -0.28 | |||
| Return On Asset | -0.13 | |||
| Profit Margin | (0.33) % | |||
| Operating Margin | (0.35) % | |||
| Current Valuation | 42.06 B | |||
| Shares Outstanding | 188.66 M | |||
| Shares Owned By Insiders | 0.81 % | |||
| Shares Owned By Institutions | 88.82 % | |||
| Number Of Shares Shorted | 9.58 M | |||
| Price To Earning | 32.75 X | |||
| Price To Book | 16.93 X | |||
| Price To Sales | 18.76 X | |||
| Revenue | 1.96 B | |||
| Gross Profit | 207.99 M | |||
| EBITDA | (623.62 M) | |||
| Net Income | (610.31 M) | |||
| Cash And Equivalents | 1.85 B | |||
| Cash Per Share | 10.03 X | |||
| Total Debt | 43.47 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 4.57 X | |||
| Book Value Per Share | 13.52 X | |||
| Cash Flow From Operations | (453.75 M) | |||
| Short Ratio | 8.69 X | |||
| Earnings Per Share | (4.01) X | |||
| Price To Earnings To Growth | 18.53 X | |||
| Target Price | 228.91 | |||
| Number Of Employees | 3.26 K | |||
| Beta | 0.32 | |||
| Market Capitalization | 43.15 B | |||
| Total Asset | 3.67 B | |||
| Retained Earnings | (2.15 B) | |||
| Working Capital | 1.98 B | |||
| Current Asset | 771.06 M | |||
| Current Liabilities | 134.27 M | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 3.67 B |
About Seagen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Seagen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Seagen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Seagen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington. Seagen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2675 people.
Currently Active Assets on Macroaxis
| LAAC | Lithium Americas Corp | |
| F | Ford Motor | |
| CHPT | ChargePoint Holdings | |
| AXL | American Axle Manufacturing | |
| ICLN | iShares Global Clean |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Seagen Inc information on this page should be used as a complementary analysis to other Seagen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Seagen Stock
If you are still planning to invest in Seagen Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Seagen's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |